Dr. Yazan Abdallah is an Honorary Clinical Lecturer in the Department of Metabolism, Digestion and Reproduction at Imperial College London's Faculty of Medicine. He is a Consultant in Reproductive Medicine and Surgery at St Mary's Hospital, Manchester, with dual GMC accreditation in Obstetrics & Gynaecology and Reproductive Medicine. MD (2005), PhD (2014) H-index of 18 with over 30 peer-reviewed publications Specializes in fertility preservation for cancer survivors His research focuses on: Reproductive Medicine Ultrasound Imaging (3D, blood flow studies) Recurrent Miscarriage Diagnosis Uterine Transplantation Immune Suppression Cesarean Scar Analysis His work has led to international guideline changes (RCOG/NICE) and collaborations with KU Leuven. He has received the National Institute for Health Research (NIHR) Award and participated in the International Ovarian Tumor Analysis (IOTA) group. Recent publications analyze pregnancy outcomes, diagnostic ultrasound reproducibility, and fertility preservation in oncology.
Craig J. Chaya, MD , is Associate Professor (Clinical) of Ophthalmology at the University of Utah and serves as Division Chief of Global Ophthalmology at the John A. Moran Eye Center. He practices anterior segment ophthalmology and surgery across multiple clinical sites including the University of Utah flagship campus, Redwood and Midvalley Health Centers, Salt Lake Veterans Medical Center, and Primary Children’s Medical Center. Education & Training: MD – Loma Linda University School of Medicine, Loma Linda, CA BS – La Sierra University, Riverside, CA (Human Biology) Residency – Internal Medicine, West Los Angeles VA Medical Center Residency – Ophthalmology, Texas Tech University Health Sciences Center Fellowship – Glaucoma, University of Utah / John A. Moran Eye Center Fellowship – International Ophthalmology, Himalayan Cataract Project/Freedom Foundation (Kathmandu & Hetauda, Nepal) Clinical & Research Focus Dr. Chaya specializes in the medical and surgical management of complex cataracts and glaucoma, emphasizing micro-invasive glaucoma surgery (MIGS) and novel surgical devices. He is deeply engaged in global ophthalmology, directing international outreach and blindness-prevention programs across Guam, Micronesia, Ghana, Haiti, Thailand, and Nepal. His research portfolio includes prospective surgical outcome studies, epidemiologic analyses of exfoliation syndrome, and innovative techniques such as gonioscopy-assisted transluminal trabeculotomy (GATT). Selected Publication Themes Recent peer-reviewed work spans three major domains: (1) refinement of trabeculotomy and cyclodialysis techniques to improve safety and efficacy in glaucoma surgery, (2) epidemiologic and genetic investigations into exfoliation syndrome and glaucoma among underserved populations, and (3) development of global ophthalmology training curricula and COVID-19-adapted outreach models. Scientific & Professional Recognition Board Certified, American Board of Ophthalmology Associate Professor (Clinical), University of Utah Department of Ophthalmology & Visual Sciences Division Chief, Global Ophthalmology, John A. Moran Eye Center Teaching & Mentorship Dr. Chaya supervises residents and fellows in complex anterior segment surgery and global ophthalmology rotations. He contributes to Moran CORE educational videos and lectures on MIGS techniques and international surgical outreach.
Yi-Ju Li is Professor of Biostatistics & Bioinformatics at Duke University, where she is also a Member of the Duke Molecular Physiology Institute and part of the Division of Integrative Genomics. Her academic journey at Duke includes progression from Assistant Professor to Associate Professor and now to her current position as full Professor since 2021. Professor Li's research focuses on statistical genetics, particularly the development of statistical methods for understanding the genetic predisposition of human complex diseases. Her work encompasses family-based association methods for quantitative traits, detection of X-linked genes for disease risk, analysis of next generation sequencing data for rare variants, and applications in Alzheimer's disease, Fuchs endothelial corneal dystrophy, and peri-operative genomic studies. She has made significant contributions to understanding the genetic basis of age-at-onset of Alzheimer disease and genetic risk factors for postoperative outcomes in patients undergoing cardiac surgery. Her recent publications reveal a strong trend toward translational research with clinical applications, particularly in drug-induced liver injury, cardiovascular outcomes after surgery, and genetic risk factors for various conditions. Her work bridges statistical methodology development with practical applications in multiple disease areas, demonstrating versatility across hepatic, neurological, cardiovascular, and ophthalmological domains. Professor Li serves as Co-Investigator on multiple significant research grants, including the Drug Induced Liver Injury Network Data Coordinating Center (NIH, 2003-2028), Proteomic Biomarkers Predicting Osteoarthritis Onset and Progression (DoD, 2025-2027), and Neurocognition & Greater Maintenance of Sinus Rhythm in AF (NIA, 2021-2026). Her grant portfolio spans multiple funding agencies including NIH, Department of Defense, and various institutes within NIH. She is actively involved in the Duke Center for Statistical Genetics and Genomics, collaborating with researchers across multiple disciplines to advance genomic research methodologies and applications. Her work demonstrates strong interdisciplinary collaboration between biostatistics, medicine, and clinical research teams at Duke University.
Chris Quinn is a Senior Lecturer in Veterinary Anaesthesia and leader of the Anaesthesia Team at the School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW. He is a specialist veterinary anaesthetist registered with the NSW Veterinary Practitioners Board, with dual board certification from the European and American Colleges of Veterinary Anaesthesia and Analgesia (DECVAA, DACVAA). He also holds membership in the Australian and New Zealand College of Veterinary Scientists (MANZCVS) in both Veterinary Anaesthesia and Critical Care and Medicine of Horses. His research interests are centered on improving peri-operative safety, particularly in relation to renal function and haemodynamic stability. Key areas include: Prevention of acute kidney injury (AKI) in surgical animals Management of hypotension during anaesthesia Renal monitoring in dogs and horses Critical care of large herbivores and small animals Recent publications show a strong focus on evidence-based protocols for hypotension treatment, urinary catheter complications in horses, and renal tubular injury post-desexing in dogs. His work combines clinical research with direct application in teaching and hospital practice. Notable scientific recognition includes an external award in 2017 for research on the incidence of AKI in dogs undergoing routine surgery. Determining the incidence of perioperative acute kidney injury in dogs undergoing routine surgery (2017, External Award) Chris Quinn has supervised honours students, including R. Rotne, on projects related to glomerular filtration rates and hydration effects on haemodynamics. His research is supported through institutional and professional engagement, including active membership in the Australian and New Zealand College of Veterinary Scientists, where he also serves as an examiner. He leads the Anaesthesia Team at CSU, integrating teaching, clinical service, and research in both equine and small animal hospitals.
Jinshuo Li is a Research Fellow and Health Economist at the University of York's Health Sciences department. With extensive experience in health economics and public health interventions, she has established herself as a leading researcher in economic evaluation of clinical and public health programs. Her work spans multiple countries and diverse populations, addressing critical health challenges through rigorous methodological approaches. Dr. Li's educational background includes a BA in Public Health Administration and an MPhil in Health Economics, Policy and Management. She began her studies at the Department of Public Health, Fudan University in Shanghai, China, followed by professional experience at the Shanghai Huangpu Centre for Disease Control and Prevention. She furthered her training at the Department of Medicine, University of Oslo, Norway, and worked as an Analyst for the National Association Against Substance Abuse in Oslo before joining the University of York. Her primary research interests focus on the economic evaluation of public health and clinical interventions, with particular expertise in smoking cessation programs, mental health services, diabetes management, and substance abuse treatment. Dr. Li has led and contributed to numerous large-scale research projects including ADVANCE, ARROW, CASPER PLUS, SCIMITAR+, CATFISH, Y-SBNT, TEC study, PROTECT, Preloading trial, ODHIN, and web-based self-management support for diabetes. Her methodological strengths include cost-effectiveness analysis, randomized controlled trials, and implementation research across diverse settings from emergency departments to homeless support centers. Dr. Li's publication record demonstrates a strong trajectory of high-impact research, with recent work focusing on innovative approaches to smoking cessation (particularly among vulnerable populations), mental health interventions, and integrated care models. Her research frequently addresses health inequalities and seeks to develop evidence-based solutions for complex health challenges through rigorous economic evaluation. As a member of the Trials and Statistics research group at the University of York, Dr. Li collaborates extensively with multidisciplinary teams across the UK and internationally. Her work has significant policy implications, particularly in tobacco control, mental health services, and public health economics.
Thomas Scheeren is a Professor at the University of Groningen's Faculty of Medical Sciences, affiliated with the UMCG (University Medical Center Groningen) in the CAPE department. He specializes in hemodynamic monitoring, critical care, anesthesiology, and perioperative medicine. His career includes roles at Germany's Heinrich-Heine-University Düsseldorf (1988–2004) and University Hospital Rostock (2004–2009). Current Position: Professor of Anesthesiology & Intensive Care Institution: University of Groningen/UMCG Research Focus : Hemodynamic stability in surgical and critically ill patients Advanced monitoring techniques (e.g., near-infrared spectroscopy) Perioperative complications prediction Fluid management and transfusion strategies Recent Article Trends : Focus on AI-driven hypotension classification, plasma transfusion protocols, and pediatric cardiac surgery outcomes using non-invasive monitoring. His work bridges clinical practice and machine learning innovations. Awards : 2011: Best Scientific Presentation (AIOS) 2005: Best Abstract Presenter (ESICM) 1999: Karl-Thomas-Award (German Anesthesiology Society) Grants & Advising : Active in supervising research projects (10 listed) and contributing to international studies like the InPUT plasma transfusion trial. His work aligns with UN SDGs for health (SDG 3).
Julie Vassart is a Researcher at the University of Namur's Namur Research Institute for Life Sciences and Clinical Pharmacology Research Group. Her work focuses on anticoagulant therapy monitoring, particularly Direct Oral Anticoagulants (DOACs), with active involvement in multiple national and international projects including the BIOCOAG initiative and FXI(a) inhibitor management studies. Her educational background includes: Master in Pharmaceutical Sciences (2022), University of Namur Dr. Vassart's research centers on developing and validating rapid diagnostic tools for anticoagulant monitoring, with emphasis on DOAC Dipstick accuracy in perioperative settings and novel anticoagulants like asundexian. Her work bridges clinical pharmacology, hematology, and analytical chemistry to improve patient safety during anticoagulation therapy. Current projects investigate intrinsic pathway inhibitors and real-time anticoagulant level assessment. Recent publications demonstrate a clear trend toward point-of-care anticoagulant monitoring solutions, with significant contributions to expert consensus guidelines for DOAC testing. Her research spans method validation against gold-standard techniques (UHPLC-MS/MS), clinical applicability in surgical contexts, and novel anticoagulant impact on coagulation pathways. Scientific recognition includes: Travel award (2024) for conference participation She actively contributes to 3 major research projects: the long-running BIOCOAG project (since 2011) assessing anticoagulation control biology, the FXI(a) inhibitors PhD project (2022–present), and collaborative studies with international consortia. Her work is presented regularly at premier hemostasis conferences including EuroThrombosis and the Belgian Society on Thrombosis and Haemostasis meetings. Dr. Vassart operates within the Clinical Pharmacology Research Group at the Namur Thrombosis and Hemostasis Center (NTHC), which specializes in anticoagulant pharmacology, coagulation assay development, and thrombosis risk assessment using advanced laboratory techniques.
Pere Planellas Gine is an Associate Professor of Surgery at the University of Girona (UdG) and an Assistant Surgeon in the Colorectal Surgery Unit of Josep Trueta Hospital in Girona. His dual role integrates cutting-edge clinical practice with university teaching and translational research. Research Focus: Minimally-invasive approaches to colorectal cancer, including laparoscopic, robotic and transanal techniques. Functional and oncological outcomes in colorectal surgery (THAR, ECME, PREMARE, BIORECTE studies). Pelvic-floor disorders and advanced abdominal-wall surgery. Development and implementation of Enhanced Recovery After Surgery (ERAS) protocols and evidence-based clinical guidelines. As Principal Investigator or protocol lead, Dr Planellas has authored numerous institutional guidelines on colorectal pathology and peri-operative care, and he collaborates closely with the Department of Anatomy at UdG on anatomical studies underpinning surgical innovation. Clinical & Academic Affiliations: Colorectal Surgery Unit, Josep Trueta Hospital (accredited Centre of Excellence by the Spanish Association of Coloproctology). Research Group in General and Digestive Surgery, University of Girona. Contact: pere.planellas@udg.edu
Dr. Sarju Ganatra is an Assistant Professor at the T.H. Chan School of Medicine , affiliated with UMass Chan Medical School and Lahey Hospital and Medical Center . His research bridges cardiology and oncology, focusing on cardiotoxicity related to cancer therapies, environmental determinants of cardiovascular disease , and health equity in cardio-oncology. Education : MBBS from Gujarat University , India. Dr. Ganatra leads studies on the cardiovascular impacts of GLP-1 receptor agonists , SGLT2 inhibitors , and immune checkpoint inhibitors , with recent work analyzing climate vulnerability and microplastics in cardiovascular-kidney-metabolic disease. His publications emphasize real-world data , pharmacovigilance , and global health perspectives. Key trends in his 2024-2025 publications include: Intersections between climate change and cardiovascular health ; GLP-1 agonists in diabetes and heart failure ; Microplastics and neurological disabilities ; SGLT2 inhibitors for cancer therapy-related cardiotoxicity . Dr. Ganatra collaborates internationally on cardio-oncology registries and multipollutant studies , advocating for SDOH screening tools and planetary health integration in medical education.
Ronelle Mouton serves as Honorary Professor of Anaesthesia at Bristol Medical School, University of Bristol, and Consultant Anaesthetist at North Bristol NHS Trust since February 2008. She holds key external roles including Chair of the Vascular Anaesthesia Society of Great Britain & Ireland (2019-present), Royal College of Anaesthetists NAP7 Steering Panel member (2020-present), and Perioperative Medicine Clinical Trials Network Board member (2023-present). Her research specializes in vascular anaesthesia, perioperative clinical trial methodology, and tobacco cessation frameworks. She develops standardized reporting protocols for vascular and anaesthesia interventions, with strong emphasis on systematic reviews and randomized controlled trials in perioperative medicine. Current work focuses on improving outcomes in vascular/cardiothoracic surgery through evidence-based perioperative interventions. Recent publications (2025) establish frameworks for endovascular trials (Endo-STAR) and anaesthesia interventions, alongside systematic reviews of intensive care outcomes. These demonstrate consistent focus on trial methodology standardization, vascular surgery outcomes, and perioperative risk reduction across multiple high-impact surgical contexts. Her major honors include best research presentation at the Association of Anaesthetists meeting (2023), VASGBI Chair appointment (2019), and POMCTN Chief Investigator role (2020). She leads three principal investigator projects: CAMELOT trial on laparotomy analgesia (2022-2026), PROTECTOR tobacco cessation study (2023-2024), and anaesthesia intervention reporting frameworks project (2021-2024), all targeting perioperative care enhancement through clinical evidence generation.
Dr. Lyen C. Huang is a tenured Associate Professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah's Spencer Fox Eccles School of Medicine, with an adjunct appointment in Population Health Sciences. He specializes in complex minimally-invasive (laparoscopic/robotic) surgery for colorectal cancers, inflammatory bowel disease, and diverticulitis at Huntsman Cancer Institute and University of Utah Hospital. His educational background includes: B.S. in Symbolic Systems (minor in Political Science) from Stanford University M.D. from Stanford University School of Medicine M.P.H. from University of Cape Town General Surgery residency at Stanford University Colon and Rectal Surgery fellowship at Mayo Clinic Dr. Huang's research centers on implementation science to optimize peri-operative opioid stewardship through behavior change interventions, dissemination of quality/safety initiatives in rural healthcare systems, and improving cancer survivorship outcomes. His work specifically targets disparities in frontier and underserved communities, with significant contributions to NCCN colorectal cancer screening guidelines. His 15 most recent publications (2022-2024) reveal a dominant focus on opioid management (70% of articles), examining prescribing practices, disposal interventions, and trainee education, while also advancing global surgery capacity in Ghana/Cambodia and colorectal cancer epidemiology through physical activity/microbiome studies. Key scientific recognitions include: NIH K23 award from NIDA/HEAL Initiative University of Utah CTSI KL2 Career Development Scholar Fellow of the American College of Surgeons (FACS) Fellow of the American Society of Colon and Rectal Surgeons (FASCRS) Dr. Huang actively mentors medical students and surgical trainees (evident in 12/15 recent publications where mentees are acknowledged), leads NIH-funded opioid stewardship research, and directs global colorectal training programs. He serves as clinical advisor to the Utah Data Coordinating Center and co-leader of the Huntsman Cancer Institute Colorectal Cancer Research Group. He directs colorectal surgery training initiatives in Ghana and Cambodia through the University of Utah Center for Global Surgery, serves on the Annals of Surgery Open editorial board, and contributes to NCCN Colorectal Cancer Screening guidelines. His institutional roles include associate member of the HCI Cancer Control and Population Sciences program and membership in SAAS, AAS, and ASCRS.
Bodil Lund is a Professor of Oral and Maxillofacial Surgery and Head of the Department of Dental Medicine at Karolinska Institutet. She holds dual roles as a Senior Dentist and academic leader, focusing on translational research and clinical practice. Education: Docent, Karolinska Institutet (2011) Doctor of Philosophy, Department of Laboratory Medicine, Karolinska Institutet (2003) Research Interests: Antibiotic Stewardship: Optimizing antibiotic use in dentistry to combat resistance, including guideline development and educational initiatives through collaborations with national agencies like Strama. Temporomandibular Joint (TMJ) Disorders: Investigating diagnostic classification, treatment efficacy, and patient outcomes using clinical trials and basic science. Research focuses on surgical interventions, biomarkers, and non-surgical alternatives for treatment-resistant cases. Clinical Translation: Bridging epidemiology, surgery, and basic research to address gaps in dental antibiotic use and TMJ pathophysiology. Article Trends: Recent publications emphasize antibiotic use optimization, surgical outcomes (e.g., orthognathic surgery costs, TMJ arthroplasty), and patient-centered metrics like quality of life post-surgery. Themes include evidence-based practice, infection control, and interdisciplinary collaboration. Grants & Leadership: Lead the SWEREG-TMD national registry for temporomandibular disorders. Guided implementation of web-based simulation tools for dental student training. Active in strategic programs to reduce antibiotic resistance in dentistry. Labs/Teams: Collaborates with multidisciplinary groups including rheumatology, microbiology, and public health experts. Leads the Antibiotic Stewardship Research Group and the TMJ Surgery Outcomes Team.
Audra Clark, MD, is Assistant Professor of Surgery at the University of Texas Southwestern Medical Center in Dallas, where she specialises in burn surgery and surgical critical care. She completed medical school (2013), general-surgery residency (2020) and a surgical-critical-care fellowship (2021) at UT Southwestern and has remained on faculty, contributing to more than 80 peer-reviewed publications since 2016. Education & Training: MD – UT Southwestern Medical School, 2013 Post-doctoral research fellowship – UT Southwestern Medical Center, 2018 Residency in General Surgery – UT Southwestern Medical Center, 2020 Fellowship in Surgical Critical Care – UT Southwestern Medical Center, 2021 Research Focus: Dr Clark’s work spans burn resuscitation physiology, acute kidney injury after burn, operating-room efficiency, laser therapy for hypertrophic burn scar, and surgical resident education. She employs large prospective cohorts, national burn databases and translational models to investigate resuscitation endpoints, metabolic derangements and quality-improvement initiatives in burn and trauma patients. Publication Trends: Her recent output (2022-2025) emphasises advanced imaging for burn-depth assessment (multispectral short-wave infrared), ethnicity-neutral resuscitation protocols, post-burn voice outcomes, and multi-national peri-operative risk studies, reflecting a blend of technological innovation and health-services research. Grants & Clinical Programs: While specific grant numbers are not disclosed, she is the principal investigator on several quality-improvement projects within the Parkland Burn Center and participates in multicenter consortiums such as the Burn Model System and P.A.L.LI.A.T.E. geriatric-trauma collaboration. Advising & Teams: Dr Clark mentors general-surgery residents and critical-care fellows in hypothesis-driven burn research and serves on thesis committees for trainees utilising the UT Southwestern surgical database repository.
Assoc. Prof. Dr. med. Laura Neimane serves as the Dean of the Faculty of Dentistry and holds an academic appointment in the Department of Conservative Dentistry and Oral Health at Rīga Stradiņš University (RSU). She also directs the Dentistry study program. Her professional roles include leadership in dental education, research, and clinical innovation. Dr. Neimane’s research focuses on advanced imaging techniques (CBCT, 3D-printed surgical models), bone regeneration materials, and AI applications in dentistry. She leads clinical trials evaluating treatments for tooth agenesis, molar transplantation, and osteoporosis-related bone deterioration in oral contexts. Her work integrates interdisciplinary approaches, combining dental surgery, radiology, and biomaterials science. She oversees the RSU Institute of Stomatology, which supports her research on implant stability, maxillary sinus augmentation, and temporomandibular joint disorders. Recent studies emphasize improving diagnostic accuracy through AI-driven image analysis and optimizing surgical techniques using 3D-printed tools. Dr. Neimane’s contributions bridge clinical practice and academic research, contributing to advancements in dental education and patient care in Latvia and beyond.
Maarten Nijsten is a Researcher affiliated with the Faculty of Medical Sciences at the University of Groningen (UMCG) . He holds dual departmental roles in the Microbes in Health and Disease (MHD) and the Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE) . His work aligns with UN Sustainable Development Goals, particularly in advancing healthcare and reducing critical illness complications. Dr. Nijsten's research expertise spans machine perfusion , intensive care unit (ICU) diagnostics , infection biology , and metabolic monitoring . He has pioneered studies on liver preservation techniques and the application of imaging modalities like PET/CT for identifying persistent infections in critically ill patients. His work also addresses antibiotic therapy optimization and perioperative medicine challenges. Recent media highlights include commentaries on smart infusion pumps reducing medication waste in ICUs (2025). He contributed to three datasets, including liver transplantation biomarkers and myocardial infarction outcome studies. Over 198 research outputs and 11 supervised works reflect his dedication to translational research. His 2019 visiting research role at Technical University of Munich's TUM Neuroimaging Center underscores collaborative international work. While specific grants or lab affiliations aren't detailed, his contributions to organ preservation and metabolic studies suggest involvement in advanced medical research teams.
